• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 CRISPR/Cas9 靶向 AAVS1 位点并带有诱导型转基因盒用于人类多能干细胞的神经元分化。

Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.

机构信息

Department of Chemistry and Biotechnology, School of Science, Computing and Engineering Technologies, Swinburne University of Technology, Hawthorn, VIC, Australia.

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.

出版信息

Methods Mol Biol. 2022;2495:99-114. doi: 10.1007/978-1-0716-2301-5_6.

DOI:10.1007/978-1-0716-2301-5_6
PMID:35696030
Abstract

CRISPR/Cas9 system is a powerful genome-editing technology for studying genetics and cell biology. Safe harbor sites are ideal genomic locations for transgene integration with minimal interference in cellular functions. Gene targeting of the AAVS1 locus enables stable transgene expression without phenotypic effects in host cells. Here, we describe the strategy for targeting the AAVS1 site with an inducible Neurogenin-2 (Ngn2) donor template by CRISPR/Cas9 in hiPSCs, which facilitates generation of an inducible cell line that can rapidly and homogenously differentiate into excitatory neurons.

摘要

CRISPR/Cas9 系统是一种强大的基因组编辑技术,可用于研究遗传学和细胞生物学。安全港位点是转基因整合的理想基因组位置,对细胞功能的干扰最小。AAVS1 基因座的基因靶向使转基因在宿主细胞中稳定表达,而不会产生表型效应。在这里,我们描述了通过 CRISPR/Cas9 在 hiPSCs 中靶向 AAVS1 位点的诱导性神经基因 2 (Ngn2) 供体模板的策略,该策略有助于生成一种诱导性细胞系,该细胞系可以快速且均匀地分化为兴奋性神经元。

相似文献

1
Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.通过 CRISPR/Cas9 靶向 AAVS1 位点并带有诱导型转基因盒用于人类多能干细胞的神经元分化。
Methods Mol Biol. 2022;2495:99-114. doi: 10.1007/978-1-0716-2301-5_6.
2
Differential Transgene Silencing of Myeloid-Specific Promoters in the Safe Harbor Locus of Induced Pluripotent Stem Cell-Derived Myeloid Cells.诱导多能干细胞源性髓系细胞中安全港位点髓系特异性启动子的差异转基因沉默。
Hum Gene Ther. 2020 Feb;31(3-4):199-210. doi: 10.1089/hum.2019.194. Epub 2020 Jan 23.
3
Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.利用强力霉素诱导型 CRISPR-Cas9 系统对人诱导多能干细胞进行基因编辑。
Methods Mol Biol. 2022;2454:755-773. doi: 10.1007/7651_2021_348.
4
Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the locus as not an entirely safe harbour.CRISPR-Cas9靶向转基因的可变表达和沉默表明该位点并非完全安全。
F1000Res. 2019 Nov 12;8:1911. doi: 10.12688/f1000research.19894.2. eCollection 2019.
5
Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.用于在所有胚层分化细胞中稳定表达转基因的恒河猴诱导多能干细胞安全港基因编辑平台。
Mol Ther. 2017 Jan 4;25(1):44-53. doi: 10.1016/j.ymthe.2016.10.007.
6
Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.杆状病毒介导的锌指核酸酶表达靶向人诱导多能干细胞中的 AAVS1 基因座的转基因插入。
J Gene Med. 2013 Oct;15(10):384-95. doi: 10.1002/jgm.2745.
7
Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.开发基于 CRISPR/Cas9 的荧光报告人多能干细胞系用于高通量筛选。
Molecules. 2022 Apr 9;27(8):2434. doi: 10.3390/molecules27082434.
8
Generation of a CAG-EGFP tagged cell line (KSCBi017-A-2) from human induced pluripotent stem cells using CRISPR/Cas9.利用CRISPR/Cas9从人诱导多能干细胞中生成CAG-EGFP标记的细胞系(KSCBi017-A-2)。
Stem Cell Res. 2024 Mar;75:103303. doi: 10.1016/j.scr.2024.103303. Epub 2024 Jan 4.
9
Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.利用 CRISPR-Cas9 系统对血友病 B 患者来源的诱导多能干细胞进行靶向基因组编辑。
Stem Cell Res Ther. 2018 Apr 6;9(1):92. doi: 10.1186/s13287-018-0839-8.
10
Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing.通过AAVS1安全位点基因编辑,利用Tet-on操纵子驱动Cas9生成人诱导多能干细胞系。
Stem Cell Res. 2020 Dec;49:102064. doi: 10.1016/j.scr.2020.102064. Epub 2020 Oct 27.

引用本文的文献

1
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines.MALAT1在miR-34a基因敲除细胞系中的表达失调。
Noncoding RNA. 2025 Aug 5;11(4):60. doi: 10.3390/ncrna11040060.
2
CRISPR/Cas-Based Ex Vivo Gene Therapy and Lysosomal Storage Disorders: A Perspective Beyond Cas9.基于CRISPR/Cas的体外基因治疗与溶酶体贮积症:超越Cas9的视角
Cells. 2025 Jul 25;14(15):1147. doi: 10.3390/cells14151147.
3
Ngn2-Induced Differentiation of the NG108-15 Cell Line Enhances Motor Neuronal Differentiation and Neuromuscular Junction Formation.

本文引用的文献

1
An Autaptic Culture System for Standardized Analyses of iPSC-Derived Human Neurons.一种用于 iPSC 衍生的人类神经元标准化分析的自突培养系统。
Cell Rep. 2019 May 14;27(7):2212-2228.e7. doi: 10.1016/j.celrep.2019.04.059.
2
A Single-Cell Model for Synaptic Transmission and Plasticity in Human iPSC-Derived Neurons.人诱导多能干细胞源性神经元的突触传递和可塑性的单细胞模型。
Cell Rep. 2019 May 14;27(7):2199-2211.e6. doi: 10.1016/j.celrep.2019.04.058.
3
An Ultrasensitive Calcium Reporter System via CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
Ngn2诱导NG108-15细胞系分化可增强运动神经元分化和神经肌肉接头形成。
Biomolecules. 2025 Apr 29;15(5):637. doi: 10.3390/biom15050637.
4
TRAPPopathies: Severe Multisystem Disorders Caused by Variants in Genes of the Transport Protein Particle (TRAPP) Complexes.TRAPP病:由转运蛋白颗粒(TRAPP)复合体基因变异引起的严重多系统疾病。
Int J Mol Sci. 2024 Dec 12;25(24):13329. doi: 10.3390/ijms252413329.
5
Measurements of neurite extension and nucleokinesis in an iPSC-derived model system following microtubule perturbation.在微管扰动后,对诱导多能干细胞衍生模型系统中的神经突延伸和核运动进行测量。
Mol Biol Cell. 2025 Jan 1;36(1):mr1. doi: 10.1091/mbc.E24-02-0061. Epub 2024 Nov 27.
6
Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.比较不同的基因添加策略,以修饰胎盘来源的间充质基质细胞来产生 FVIII。
Front Immunol. 2022 Dec 15;13:954984. doi: 10.3389/fimmu.2022.954984. eCollection 2022.
一种通过CRISPR-Cas9介导的人类多能干细胞基因组编辑实现的超灵敏钙报告系统。
iScience. 2018 Nov 30;9:27-35. doi: 10.1016/j.isci.2018.10.007. Epub 2018 Oct 12.
4
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.CRISPR-Cas9 基因组编辑诱导 p53 介导的 DNA 损伤反应。
Nat Med. 2018 Jul;24(7):927-930. doi: 10.1038/s41591-018-0049-z. Epub 2018 Jun 11.
5
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.p53 抑制人多能干细胞中的 CRISPR-Cas9 基因编辑。
Nat Med. 2018 Jul;24(7):939-946. doi: 10.1038/s41591-018-0050-6. Epub 2018 Jun 11.
6
Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives.对AAVS1基因座进行工程改造,以在人诱导多能干细胞及其分化衍生物中实现一致且可扩展的转基因表达。
Methods. 2016 May 15;101:43-55. doi: 10.1016/j.ymeth.2015.12.012. Epub 2015 Dec 18.
7
A simple and efficient system for regulating gene expression in human pluripotent stem cells and derivatives.一种用于调控人类多能干细胞及其衍生物中基因表达的简单高效系统。
Stem Cells. 2014 May;32(5):1230-8. doi: 10.1002/stem.1653.